Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Eastman Chemical (EMN) To Hike Prices Of Selective Products

Published 02/26/2018, 08:36 PM
Updated 07/09/2023, 06:31 AM
Eastman Chemical Company (NYSE:EMN) will raise the list and off-list selling prices of few products. The price hike will be effective from Mar 1 or as contracts permit.
The company will increase the prices of acetic acid all grades, acetic acid dilute and acetic acid-anhydride blend by 2 cents per pound in North and Latin America. In North America, prices of methyl acetate and methyl acetate, high purity grade, will be raised by 5 cents per pound.
Eastman Chemical is taking appropriate pricing actions amid an escalated raw material pricing environment. High selling prices drove revenues in the company’s Chemical Intermediates segment in fourth-quarter 2017.
Eastman Chemical’s shares have rallied 30.3% over a year, outperforming the 19.7% gain of the industry it belongs to.
In the fourth quarter, Eastman Chemical’s reported earnings of $1.62 per share, up from $1.51 in the year ago-quarter. The bottom line surpassed the Zacks Consensus Estimate of $1.06. Revenues rose around 8% year over year to $2,362 million, outpacing the Zacks Consensus Estimate of $2,289.5 million.
In 2018, the company expects to drive growth on the back of growth investments, innovation and high margin products. It also sees modestly lower tax rate to support earnings growth in 2018. Eastman Chemical anticipates raw material and energy prices, especially for olefins, to be volatile this year. The company expects adjusted earnings per share growth in 2018 to be 8-12% year over year.
Meanwhile, Eastman Chemical continues to focus on cost-cutting and productivity actions that are helping it to offset raw material price inflation. The company should also gain from its strategic acquisitions, especially Taminco. Furthermore, it remains committed to reduce debt and boost shareholder returns leveraging strong free cash flows.
Eastman Chemical Company Price and Consensus
Eastman Chemical carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the chemical space are Methanex Corporation (NASDAQ:MEOH) , Arkema S.A. (OTC:ARKAY) and The Chemours Company (NYSE:CC) .
Methanex has an expected long-term earnings growth rate of 15% and flaunts a Zacks Rank #1 (Strong Buy). Its shares have gained 12.5% over a year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Arkema has an expected long-term earnings growth rate of 13.1% and carries a Zacks Rank #2 (Buy). The company’s shares have rallied 37.7% in a year.
Chemours has an expected long-term earnings growth rate of 15.5% and carries a Zacks Rank #2. Its shares have surged 51% over a year.
Zacks Top 10 Stocks for 2018
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?
Last year's 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp (NYSE:FMC). and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.


Eastman Chemical Company (EMN): Free Stock Analysis Report

Methanex Corporation (MEOH): Free Stock Analysis Report

Arkema SA (ARKAY): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

Original post
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.